Your browser doesn't support javascript.
loading
Febrile children with comorbidities at the emergency department - a multicentre observational study.
Borensztajn, Dorine M; Hagedoorn, Nienke N; Carrol, Enitan D; von Both, Ulrich; Emonts, Marieke; van der Flier, Michiel; de Groot, Ronald; Herberg, Jethro; Kohlmaier, Benno; Levin, Michael; Lim, Emma; Maconochie, Ian K; Martinon-Torres, Federico; Nijman, Ruud G; Pokorn, Marko; Rivero-Calle, Irene; Tsolia, Maria; van der Velden, Fabian J S; Vermont, Clementien; Zavadska, Dace; Zenz, Werner; Zachariasse, Joany M; Moll, Henriette A.
Afiliación
  • Borensztajn DM; Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands. d.borensztajn@erasmusmc.nl.
  • Hagedoorn NN; Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands.
  • Carrol ED; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • von Both U; Department of Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Emonts M; Liverpool Health Partners, Liverpool, UK.
  • van der Flier M; Division of Paediatric Infectious Diseases, Dr. Von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • de Groot R; DZIF, German Centre for Infection Research, Partner Site Munich, Munich, Germany.
  • Herberg J; Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Kohlmaier B; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Levin M; NIHR Newcastle Biomedical Research Centre Based at Newcastle Upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK.
  • Lim E; Department of Paediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboudumc, Nijmegen, The Netherlands.
  • Maconochie IK; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Martinon-Torres F; Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud Institute for Molecular Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Nijman RG; Radboud Center for Infectious Diseases, Radboudumc, 6525 GA, Nijmegen, The Netherlands.
  • Pokorn M; Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, UK.
  • Rivero-Calle I; Department of General Paediatrics, Medical University of Graz, Graz, Austria.
  • Tsolia M; Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, UK.
  • van der Velden FJS; Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Vermont C; Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, UK.
  • Zavadska D; Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Zenz W; Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, UK.
  • Zachariasse JM; Department of Infectious Diseases, University Medical Centre Ljubljana, Univerzitetni Klinicni Center, Ljubljana, Slovenia.
  • Moll HA; Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Eur J Pediatr ; 181(9): 3491-3500, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35796793
We aimed to describe characteristics and management of children with comorbidities attending European emergency departments (EDs) with fever. MOFICHE (Management and Outcome of Fever in children in Europe) is a prospective multicentre study (12 European EDs, 8 countries). Febrile children with comorbidities were compared to those without in terms of patient characteristics, markers of disease severity, management, and diagnosis. Comorbidity was defined as a chronic underlying condition that is expected to last > 1 year. We performed multivariable logistic regression analysis, displaying adjusted odds ratios (aOR), adjusting for patient characteristics. We included 38,110 patients, of whom 5906 (16%) had comorbidities. Most common comorbidities were pulmonary, neurologic, or prematurity. Patients with comorbidities more often were ill appearing (20 versus 16%, p < 0.001), had an ED-Paediatric Early Warning Score of > 15 (22 versus 12%, p < 0.001), or a C-reactive protein > 60 mg/l (aOR 1.4 (95%CI 1.3-1.6)). They more often required life-saving interventions (aOR 2.7, 95% CI 2.2-3.3), were treated with intravenous antibiotics (aOR 2.3, 95%CI 2.1-2.5), and were admitted to the ward (aOR 2.2, 95%CI 2.1-2.4) or paediatric intensive care unit (PICU) (aOR 5.5, 95% CI 3.8-7.9). They were more often diagnosed with serious bacterial infections (aOR 1.8, 95%CI 1.7-2.0), including sepsis/meningitis (aOR 4.6, 95%CI 3.2-6.7). Children most at risk for sepsis/meningitis were children with malignancy/immunodeficiency (aOR 14.5, 8.5-24.8), while children with psychomotor delay/neurological disease were most at risk for life-saving interventions (aOR 5.3, 4.1-6.9) or PICU admission (aOR 9.7, 6.1-15.5). CONCLUSIONS: Our data show how children with comorbidities are a population at risk, as they more often are diagnosed with bacterial infections and more often require PICU admission and life-saving interventions. WHAT IS KNOWN: • While children with comorbidity constitute a large part of ED frequent flyers, they are often excluded from studies. WHAT IS NEW: • Children with comorbidities in general are more ill upon presentation than children without comorbidities. • Children with comorbidities form a heterogeneous group; specific subgroups have an increased risk for invasive bacterial infections, while others have an increased risk of invasive interventions such as PICU admission, regardless of the cause of the fever.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Sepsis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Eur J Pediatr Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Sepsis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Eur J Pediatr Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos